ADA Updates Diabetes Care Guidelines
The American Diabetes Association has released its annual update to its "Standards of Medical Care in Diabetes."
“The field of diabetes care is rapidly changing as new research, technology, and treatments that can improve the health and well-being of people with diabetes continue to emerge,” the authors wrote. To this end, the guidelines have been reorganized to include a Diabetes Technology section, containing information previously located in other sections of the document that has now been consolidated.
Among the changes since last year:
- Glucagon-like peptide 1 receptor agonists are preferred over insulin in patients with type 2 diabetes who require injectable drugs.
- Routine glucose self-monitoring is of limited added benefit to patients who do not use insulin.
- A patient’s 10-year atherosclerotic cardiovascular disease risk should be included as part of their overall risk assessment.
- Water consumption should be emphasized, while consumption of sugar-sweetened beverages should be discouraged.
The full recommendations were published in Diabetes Care.
Summary of revisions: Standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Supplement 1):S4-S6.